JAMDA
August 1, 2022
Showing 41 - 50 of 108 results
JAMDA
July 20, 2022
Factors Associated with Potentially Harmful Medication Prescribing in Nursing Homes: A Scoping Review
To summarize current evidence regarding facility and prescriber characteristics associated with potentially harmful medication (PHM) use by residents in nursing homes (NHs), which could inform the development of interventions to reduce this potentially harmful practice.
JAMDA
July 16, 2022
Scoping Review of Randomized Trials With Discontinuation of Medicines in Older Adults
To map the randomized trial evidence describing the feasibility of discontinuing active medications with potential adverse effects in older patients.
JAMDA
June 27, 2022
Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer’s Disease and Related Dementias: A Cross-Sectional Analysis
We examined the association between nursing home (NH) characteristics and whether NHs had high or low levels of antipsychotic, benzodiazepine, or opioid prescribing to residents with Alzheimer’s disease and related dementias (ADRD). We then measured the likelihood that NHs who were high (low) prescribers o...
JAMDA
April 28, 2022
Medications Associated With Geriatric Syndromes (MAGS) and Hospitalization Risk in Home Health Care Patients
Polypharmacy is common in home health care (HHC). This study examined the prevalence of medications associated with geriatric syndromes (MAGS), its predictors, and association with subsequent hospitalization in HHC.
JAMDA
March 2, 2022
Evaluating Age as a Predictor of Postoperative Opioid Use and Prescribing Habits in Older Adults With Cancer
To assess the narcotic use of older patients after oncologic resection.
JAMDA
February 27, 2022
Greater Opioid Use Among Nursing Home Residents in Ontario, Canada During the First 2 Waves of the COVID-19 Pandemic
To examine the association between the COVID-19 pandemic and opioid use among nursing home residents followed up to March 2021, and possible variation by dementia and frailty status.
JAMDA
February 6, 2022
Potential Unintended Consequences of Antipsychotic Reduction in Ontario Nursing Homes
Antipsychotic reduction in nursing homes has been a focus of research and policy attention for several decades; however, there is evidence that these initiatives may have had unintended consequences, such as medication substitution and changes in diagnosis coding. Our objectives were to describe temporal c...
JAMDA
January 21, 2022
Optimizing Practices, Use, Care, and Services–Antipsychotics (OPUS-AP) in Long-Term Care Centers in Quebec, Canada: A Successful Scale-Up
To evaluate the scale-up of the OPUS-AP program to improve the care of residents at long-term care (LTC) centers through the systematic implementation of resident-centered approaches to care, the application of nonpharmacologic interventions for the management of behavioral and psychological symptoms of de...
JAMDA
January 14, 2022
Pragmatic Trial of Personalized Music for Agitation and Antipsychotic Use in Nursing Home Residents With Dementia
To test the effect of a personalized music intervention on agitated behaviors and medication use among long-stay nursing home residents with dementia.
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.